$LECT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Axogen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Axogen, Inc.. Get notifications about new insider transactions in Axogen, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 8.95 | 50,000 | 447,500 | 50,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Grooms Jamie Mark | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 8.95 | 50,000 | 447,500 | 50,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 8.95 | 25,000 | 223,750 | 25,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | A | 8.95 | 25,000 | 223,750 | 25,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP Sales | Option Exercise | A | 8.95 | 50,000 | 447,500 | 50,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 8.95 | 25,000 | 223,750 | 25,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Leach Kevin | Vice President Mark ... | Option Exercise | A | 8.95 | 45,000 | 402,750 | 45,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 8.95 | 5,000 | 44,750 | 5,000 | |
Jan 03 2017 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 8.95 | 110,000 | 984,500 | 110,000 | |
Oct 14 2016 | LECT | AxoGen, Inc. | Wendell Amy McBride | Director | Buy | P | 7.50 | 13,333 | 99,998 | 13,333 | 0 to 13.3 K |
Oct 14 2016 | LECT | AxoGen, Inc. | Leach Kevin | Vice President Mark ... | Buy | P | 7.50 | 2,000 | 15,000 | 2,000 | 0 to 2 K |
Oct 14 2016 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Buy | P | 7.50 | 3,333 | 24,998 | 3,333 | 0 to 3.3 K |
Oct 14 2016 | LECT | AxoGen, Inc. | Zaderej Karen L. | CEO | Buy | P | 7.50 | 10,000 | 75,000 | 242,147 | 232.1 K to 242.1 K (+4.31 %) |
Oct 14 2016 | LECT | AxoGen, Inc. | Engels John P | VP | Buy | P | 7.50 | 4,000 | 30,000 | 98,425 | 94.4 K to 98.4 K (+4.24 %) |
Oct 13 2016 | LECT | AxoGen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 8.57 | 3,750 | 32,138 | 3,750 | |
Oct 13 2016 | LECT | AxoGen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 8.57 | 25,000 | 214,250 | 25,000 | |
Aug 19 2016 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 3.60 | 3,750 | 13,500 | 30,000 | |
Aug 19 2016 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 3.60 | 3,750 | 13,500 | 325,248 | 321.5 K to 325.2 K (+1.17 %) |
Aug 10 2016 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Sell | S | 8.30 | 42,168 | 349,994 | 1,226,773 | 1.3 M to 1.2 M (-3.32 %) |
Aug 10 2016 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Sell | S | 8.63 | 107,450 | 927,294 | 1,268,941 | 1.4 M to 1.3 M (-7.81 %) |
Jul 21 2016 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 6.70 | 102,136 | 684,311 | 3,000,000 | 3.1 M to 3 M (-3.29 %) |
Jul 18 2016 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 6.87 | 41,425 | 284,590 | 3,102,136 | 3.1 M to 3.1 M (-1.32 %) |
Jul 18 2016 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 7.32 | 31,788 | 232,688 | 3,143,561 | 3.2 M to 3.1 M (-1.00 %) |
Jul 18 2016 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 7.70 | 206,090 | 1,586,893 | 3,175,349 | 3.4 M to 3.2 M (-6.09 %) |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | M | 0.27 | 3,176 | 858 | 0 | |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | M | 0.27 | 327 | 88 | 0 | |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | M | 0.27 | 634 | 171 | 0 | |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | M | 0.27 | 932 | 252 | 0 | |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | M | 0.27 | 4,752 | 1,283 | 0 | |
Jun 01 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Buy | M | 0.27 | 9,821 | 2,652 | 9,821 | 0 to 9.8 K |
May 31 2016 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 5.45 | 5,000 | 27,250 | 5,000 | |
May 31 2016 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 5.45 | 5,000 | 27,250 | 5,000 | |
May 31 2016 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 5.45 | 15,000 | 81,750 | 15,000 | |
May 31 2016 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 5.45 | 6,000 | 32,700 | 6,000 | |
Mar 16 2016 | LECT | AxoGen, Inc. | Leach Kevin | Vice President Mark ... | Option Exercise | A | 5.30 | 160,000 | 848,000 | 160,000 | |
Mar 03 2016 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 5.04 | 205,000 | 1,033,200 | 205,000 | |
Jan 06 2016 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | A | 5.05 | 25,000 | 126,250 | 25,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 5.09 | 10,000 | 50,900 | 10,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Engels John P | VP | Option Exercise | A | 5.09 | 8,500 | 43,265 | 8,500 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 5.09 | 10,000 | 50,900 | 10,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Hansen David K | Chief Accounting Of ... | Option Exercise | A | 5.09 | 8,000 | 40,720 | 8,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 5.09 | 15,000 | 76,350 | 15,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 5.09 | 15,000 | 76,350 | 15,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO, General Counse ... | Option Exercise | A | 3.38 | 83,000 | 280,540 | 83,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO, General Counse ... | Option Exercise | A | 5.09 | 9,000 | 45,810 | 9,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP Sales | Option Exercise | A | 5.09 | 20,000 | 101,800 | 20,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 5.09 | 210,000 | 1,068,900 | 210,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Option Exercise | A | 5.09 | 15,000 | 76,350 | 15,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 5.00 | 15,000 | 75,000 | 15,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | Grooms Jamie Mark | Director | Option Exercise | A | 5.09 | 15,000 | 76,350 | 15,000 | |
Dec 30 2015 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 5.09 | 20,000 | 101,800 | 20,000 | |
Nov 12 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 3.60 | 11,250 | 40,500 | 18,750 | |
Nov 12 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 3.60 | 11,250 | 40,500 | 321,498 | 310.2 K to 321.5 K (+3.63 %) |
Nov 12 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Sell | S | 5.70 | 6,013 | 34,274 | 310,248 | 316.3 K to 310.2 K (-1.90 %) |
Sep 24 2015 | LECT | AxoGen, Inc. | Donovan Michael Patrick | Vice President, Ope ... | Option Exercise | A | 5.14 | 25,000 | 128,500 | 25,000 | |
Sep 22 2015 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 5.50 | 345,000 | 1,897,983 | 3,381,439 | 3.7 M to 3.4 M (-9.26 %) |
Sep 10 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 2.75 | 13,000 | 35,750 | 316,261 | 303.3 K to 316.3 K (+4.29 %) |
Jun 05 2015 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Buy | P | 3.10 | 6,500 | 20,150 | 50,000 | 43.5 K to 50 K (+14.94 %) |
Jun 03 2015 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Finacial Offi ... | Buy | P | 3.08 | 100 | 308 | 25,000 | 24.9 K to 25 K (+0.40 %) |
Jun 03 2015 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Finacial Offi ... | Buy | P | 3.07 | 200 | 614 | 24,900 | 24.7 K to 24.9 K (+0.81 %) |
Jun 03 2015 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Finacial Offi ... | Buy | P | 3.06 | 4,600 | 14,076 | 24,700 | 20.1 K to 24.7 K (+22.89 %) |
Jun 03 2015 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Finacial Offi ... | Buy | P | 3.05 | 100 | 305 | 20,100 | 20 K to 20.1 K (+0.50 %) |
May 29 2015 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 3.11 | 200 | 622 | 232,147 | 231.9 K to 232.1 K (+0.09 %) |
May 29 2015 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 3.10 | 500 | 1,550 | 231,947 | 231.4 K to 231.9 K (+0.22 %) |
May 29 2015 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 3.17 | 2,625 | 8,321 | 231,447 | 228.8 K to 231.4 K (+1.15 %) |
Apr 09 2015 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 3.25 | 144,385 | 469,251 | 3,726,439 | 3.9 M to 3.7 M (-3.73 %) |
Mar 17 2015 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP of Sales | Option Exercise | A | 3.20 | 120,000 | 384,000 | 233,000 | |
Feb 12 2015 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Grant | A | 2.75 | 9,600 | 26,400 | 228,822 | 219.2 K to 228.8 K (+4.38 %) |
Feb 12 2015 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 2.75 | 4,800 | 13,200 | 48,902 | 44.1 K to 48.9 K (+10.88 %) |
Feb 12 2015 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP of Sales | Grant | A | 2.75 | 4,400 | 12,100 | 34,400 | 30 K to 34.4 K (+14.67 %) |
Jan 06 2015 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Option Exercise | A | 3.60 | 15,000 | 54,000 | 55,000 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Sell | S | 3.15 | 2,342 | 7,377 | 1,376,392 | 1.4 M to 1.4 M (-0.17 %) |
Jan 06 2015 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Sell | S | 3.06 | 47,658 | 145,714 | 1,378,734 | 1.4 M to 1.4 M (-3.34 %) |
Jan 06 2015 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 43,000 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Harper John Frederick | Director | Option Exercise | A | 3.60 | 15,000 | 54,000 | 72,542 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Harper John Frederick | Director | Option Exercise | A | 4.81 | 15,000 | 72,150 | 57,542 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 3.60 | 15,000 | 54,000 | 75,000 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 4.81 | 15,000 | 72,150 | 60,000 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Grooms Jamie Mark | Director | Option Exercise | A | 3.60 | 15,000 | 54,000 | 178,862 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Grooms Jamie Mark | Director | Option Exercise | A | 4.81 | 15,000 | 72,150 | 163,862 | |
Jan 06 2015 | LECT | AxoGen, Inc. | Grooms Jamie Mark | Director | Option Exercise | A | 2.75 | 13,000 | 35,750 | 148,862 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 3.67 | 33,000 | 121,110 | 308,000 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 3.67 | 27,000 | 99,090 | 275,000 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Option Exercise | A | 3.67 | 19,000 | 69,730 | 405,056 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Option Exercise | A | 3.67 | 62,000 | 227,540 | 386,056 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Engels John P | Vice President | Option Exercise | A | 3.67 | 8,500 | 31,195 | 129,037 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | A | 3.67 | 8,500 | 31,195 | 70,328 | |
Dec 31 2014 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP of Sales | Option Exercise | A | 3.67 | 10,000 | 36,700 | 113,000 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Schiaparelli Jill F | Chief Marketing Off ... | Option Exercise | A | 3.67 | 19,000 | 69,730 | 132,413 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Schiaparelli Jill F | Chief Marketing Off ... | Option Exercise | A | 3.67 | 12,500 | 45,875 | 113,413 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Hansen David K | Corporate Controlle ... | Option Exercise | A | 3.67 | 19,000 | 69,730 | 80,322 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Hansen David K | Corporate Controlle ... | Option Exercise | A | 3.67 | 10,000 | 36,700 | 61,322 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Option Exercise | A | 3.67 | 33,000 | 121,110 | 223,000 | |
Dec 31 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Option Exercise | A | 3.67 | 15,000 | 55,050 | 190,000 | |
Dec 31 2014 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Option Exercise | A | 3.67 | 10,000 | 36,700 | 70,328 | |
Dec 11 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 3.06 | 10,000 | 30,600 | 10,000 | 0 to 10 K |
Dec 03 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Grant | A | 2.94 | 6,000 | 17,640 | 43,500 | 37.5 K to 43.5 K (+16.00 %) |
Oct 10 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO | Option Exercise | A | 2.46 | 16,000 | 39,360 | 248,000 | |
Oct 02 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 1.07 | 290 | 310 | 28,000 | |
Oct 02 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 1.07 | 290 | 310 | 303,261 | 303 K to 303.3 K (+0.10 %) |
Aug 15 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.30 | 5,000 | 11,475 | 302,971 | 298 K to 303 K (+1.68 %) |
Aug 15 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.29 | 10,000 | 22,900 | 297,971 | 288 K to 298 K (+3.47 %) |
Aug 15 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.29 | 5,000 | 11,425 | 287,971 | 283 K to 288 K (+1.77 %) |
Aug 12 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Grant | A | 2.31 | 2,500 | 5,775 | 37,500 | 35 K to 37.5 K (+7.14 %) |
Aug 12 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Grant | A | 2.30 | 5,000 | 11,500 | 35,000 | 30 K to 35 K (+16.67 %) |
Aug 11 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.31 | 11,000 | 25,410 | 282,971 | 272 K to 283 K (+4.04 %) |
Jun 04 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 2.43 | 5,000 | 12,150 | 334,056 | 329.1 K to 334.1 K (+1.52 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.55 | 200 | 510 | 10,000 | 9.8 K to 10 K (+2.04 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.55 | 1,700 | 4,327 | 9,800 | 8.1 K to 9.8 K (+20.99 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.55 | 2,600 | 6,630 | 8,100 | 5.5 K to 8.1 K (+47.27 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.57 | 200 | 513 | 5,500 | 5.3 K to 5.5 K (+3.77 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.59 | 200 | 518 | 5,300 | 5.1 K to 5.3 K (+3.92 %) |
Jun 10 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Buy | P | 2.60 | 5,100 | 13,260 | 5,100 | 0 to 5.1 K |
Jun 04 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO | Buy | P | 2.34 | 200 | 468 | 29,518 | 29.3 K to 29.5 K (+0.68 %) |
Jun 04 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO | Buy | P | 2.45 | 5,000 | 12,250 | 29,318 | 24.3 K to 29.3 K (+20.56 %) |
Jun 04 2014 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP of Sales | Option Exercise | A | 2.86 | 30,000 | 85,800 | 103,000 | |
Jun 04 2014 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Option Exercise | A | 2.86 | 10,000 | 28,600 | 25,000 | |
May 22 2014 | LECT | AxoGen, Inc. | Schiaparelli Jill F | SVP, Bus. Strategy& ... | Buy | P | 2.63 | 2,000 | 5,260 | 12,750 | 10.8 K to 12.8 K (+18.60 %) |
Jun 04 2014 | LECT | AxoGen, Inc. | Johnston Lee Robert Jr | Chief Financial Off ... | Option Exercise | A | 2.58 | 175,000 | 451,500 | 175,000 | |
May 13 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 2.70 | 5,000 | 13,500 | 329,056 | 324.1 K to 329.1 K (+1.54 %) |
May 12 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Option Exercise | A | 4.81 | 15,000 | 72,150 | 40,000 | |
May 12 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Option Exercise | A | 2.75 | 13,000 | 35,750 | 25,000 | |
May 12 2014 | LECT | AxoGen, Inc. | Mandato Joseph M | Director | Grant | A | 2.64 | 15,000 | 39,600 | 30,000 | 15 K to 30 K (+100.00 %) |
May 08 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.60 | 1,487 | 3,866 | 271,971 | 270.5 K to 272 K (+0.55 %) |
May 08 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | P | 2.60 | 490 | 1,274 | 270,484 | 270 K to 270.5 K (+0.18 %) |
Apr 28 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 4.81 | 15,000 | 72,150 | 28,290 | |
Apr 28 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 2.75 | 12,000 | 33,000 | 13,290 | |
Apr 28 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Option Exercise | M | 0.27 | 5,007 | 1,352 | 25,290 | |
Apr 28 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 2.75 | 12,000 | 33,000 | 269,994 | 258 K to 270 K (+4.65 %) |
Apr 28 2014 | LECT | AxoGen, Inc. | Gold Mark Stephen | Director | Buy | M | 0.27 | 5,007 | 1,352 | 257,994 | 253 K to 258 K (+1.98 %) |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Option Exercise | M | 0.27 | 72,222 | 19,500 | 324,056 | |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Option Exercise | M | 0.27 | 126 | 34 | 251,834 | |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | M | 0.27 | 72,222 | 19,500 | 209,222 | 137 K to 209.2 K (+52.72 %) |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | M | 0.27 | 126 | 34 | 137,000 | 136.9 K to 137 K (+0.09 %) |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 3.47 | 572 | 1,985 | 136,874 | 136.3 K to 136.9 K (+0.42 %) |
Mar 17 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Buy | P | 3.50 | 928 | 3,248 | 136,302 | 135.4 K to 136.3 K (+0.69 %) |
Jan 06 2014 | LECT | AxoGen, Inc. | Engels John P | Vice President | Option Exercise | A | 4.81 | 5,000 | 24,050 | 120,537 | |
Jan 06 2014 | LECT | AxoGen, Inc. | MCCARREY SHAWN F | SVP of Sales | Option Exercise | A | 4.81 | 5,000 | 24,050 | 73,000 | |
Jan 06 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO | Option Exercise | A | 4.81 | 15,000 | 72,150 | 232,000 | |
Jan 06 2014 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO | Grant | A | 0.00 | 6,250 | 0 | 38,901 | 32.7 K to 38.9 K (+19.14 %) |
Jan 06 2014 | LECT | AxoGen, Inc. | Hansen David K | Corporate Controlle ... | Option Exercise | A | 4.81 | 5,000 | 24,050 | 51,322 | |
Jan 06 2014 | LECT | AxoGen, Inc. | Schiaparelli Jill F | SVP, Bus. Strategy& ... | Option Exercise | A | 4.81 | 10,000 | 48,100 | 100,913 | |
Jan 06 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Option Exercise | A | 4.81 | 31,000 | 149,110 | 396,404 | |
Jan 06 2014 | LECT | AxoGen, Inc. | Zaderej Karen L. | Chief Executive Off ... | Grant | A | 0.00 | 6,250 | 0 | 135,374 | 129.1 K to 135.4 K (+4.84 %) |
Jan 06 2014 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | A | 4.81 | 5,000 | 24,050 | 67,494 |